Literature DB >> 28693923

Diverse functions of the prion protein - Does proteolytic processing hold the key?

Luise Linsenmeier1, Hermann C Altmeppen1, Sebastian Wetzel2, Behnam Mohammadi1, Paul Saftig2, Markus Glatzel3.   

Abstract

Proteolytic processing of the cellular and disease-associated form of the prion protein leads to generation of bioactive soluble prion protein fragments and modifies the structure and function of its cell-bound form. The nature of proteases responsible for shedding, α-, β-, and γ-cleavage of the prion protein are only partially identified and their regulation is largely unknown. Here, we provide an overview of the increasingly multifaceted picture of prion protein proteolysis and shed light on physiological and pathological roles associated with these cleavages. This article is part of a Special Issue entitled: Proteolysis as a Regulatory Event in Pathophysiology edited by Stefan Rose-John.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ADAM10; Neurodegeneration; Neuropathology; Prion; Proteolysis; Shedding

Mesh:

Substances:

Year:  2017        PMID: 28693923     DOI: 10.1016/j.bbamcr.2017.06.022

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Cell Res        ISSN: 0167-4889            Impact factor:   4.739


  25 in total

1.  Novel quaternary structures of the human prion protein globular domain.

Authors:  Leandro Oliveira Bortot; Victor Lopes Rangel; Francesca A Pavlovici; Kamel El Omari; Armin Wagner; Jose Brandao-Neto; Romain Talon; Frank von Delft; Andrew G Reidenbach; Sonia M Vallabh; Eric Vallabh Minikel; Stuart Schreiber; Maria Cristina Nonato
Journal:  Biochimie       Date:  2021-09-10       Impact factor: 4.079

Review 2.  Anchorless risk or released benefit? An updated view on the ADAM10-mediated shedding of the prion protein.

Authors:  Behnam Mohammadi; Feizhi Song; Andreu Matamoros-Angles; Mohsin Shafiq; Markus Damme; Berta Puig; Markus Glatzel; Hermann Clemens Altmeppen
Journal:  Cell Tissue Res       Date:  2022-01-27       Impact factor: 5.249

3.  β-Cleavage of the prion protein in the human eye: Implications for the spread of infectious prions and human ocular disorders.

Authors:  Suman Chaudhary; Ajay Ashok; Aaron S Wise; Neil A Rana; Alexander E Kritikos; Ewald Lindner; Neena Singh
Journal:  Exp Eye Res       Date:  2021-10-07       Impact factor: 3.467

Review 4.  Cell biology of prion strains in vivo and in vitro.

Authors:  Daniel Shoup; Suzette A Priola
Journal:  Cell Tissue Res       Date:  2022-02-02       Impact factor: 5.249

5.  Disordered structure and flexible roles: using the prion protein N1 fragment for neuroprotective and regenerative therapy.

Authors:  Behnam Mohammadi; Markus Glatzel; Hermann Clemens Altmeppen
Journal:  Neural Regen Res       Date:  2021-07       Impact factor: 5.135

6.  Structural and mechanistic aspects influencing the ADAM10-mediated shedding of the prion protein.

Authors:  Luise Linsenmeier; Behnam Mohammadi; Sebastian Wetzel; Berta Puig; Walker S Jackson; Alexander Hartmann; Keiji Uchiyama; Suehiro Sakaguchi; Kristina Endres; Jörg Tatzelt; Paul Saftig; Markus Glatzel; Hermann C Altmeppen
Journal:  Mol Neurodegener       Date:  2018-04-06       Impact factor: 14.195

Review 7.  Prion Proteins Without the Glycophosphatidylinositol Anchor: Potential Biomarkers in Neurodegenerative Diseases.

Authors:  Valerija Kovač; Vladka Čurin Šerbec
Journal:  Biomark Insights       Date:  2018-02-06

8.  Caprine PRNP polymorphisms N146S and Q222K are associated with proteolytic cleavage of PrPC.

Authors:  Sally A Madsen-Bouterse; Paula Stewart; Helen Williamson; David A Schneider; Wilfred Goldmann
Journal:  Genet Sel Evol       Date:  2021-06-19       Impact factor: 4.297

Review 9.  Cellular and Molecular Mechanisms of Prion Disease.

Authors:  Christina J Sigurdson; Jason C Bartz; Markus Glatzel
Journal:  Annu Rev Pathol       Date:  2018-10-24       Impact factor: 32.350

10.  The vascular endothelial cell-expressed prion protein doppel promotes angiogenesis and blood-brain barrier development.

Authors:  Zhihua Chen; John E Morales; Naze Avci; Paola A Guerrero; Ganesh Rao; Je Hoon Seo; Joseph H McCarty
Journal:  Development       Date:  2020-09-23       Impact factor: 6.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.